Antibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 15000-1-AP - Provider product page

- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#15000-1-AP, RRID:AB_2213189
- Product name
- UNKL antibody
- Antibody type
- Polyclonal
- Description
- UNKL antibody (Cat. #15000-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Clemastine fumarate accelerates accumulation of disability in progressive multiple sclerosis by enhancing pyroptosis.
N-acetyltransferase 10 promotes glioblastoma malignancy via mRNA stabilization of jumonji and AT-rich interaction domain containing 2.
An orally administered gene editing nanoparticle boosts chemo-immunotherapy in colorectal cancer.
Dominant follicle-targeted nanocarriers for GH delivery to alleviate premature ovarian insufficiency.
WEE1 inhibitor exerts synergistic effect with KRAS G12C inhibitor via MYBL2-RRM2 axis in KRAS(G12C)-mutant lung cancer.
Clinical characteristics of gastrointestinal stromal tumors with hypoglycemia.
Celastrol inhibits gastric cancer cell proliferation, migration, and invasion via the FOXA1/CLDN4 axis.
Tectonic 1 Is a Key Regulator of Cell Proliferation in Pancreatic Cancer.
Kocot J, Kosa P, Ashida S, Pirjanian NA, Goldbach-Mansky R, Peterson K, Fossati V, Holland SM, Bielekova B
The Journal of clinical investigation 2025 May 15;135(10)
The Journal of clinical investigation 2025 May 15;135(10)
N-acetyltransferase 10 promotes glioblastoma malignancy via mRNA stabilization of jumonji and AT-rich interaction domain containing 2.
Inoki T, Tsuruta A, Masakado Y, Kai Y, Yoshida Y, Matsunaga N, Ohdo S, Koyanagi S
The Journal of biological chemistry 2025 Jun;301(6):108544
The Journal of biological chemistry 2025 Jun;301(6):108544
An orally administered gene editing nanoparticle boosts chemo-immunotherapy in colorectal cancer.
Zhao K, Yan Y, Jin XK, Pan T, Zhang SM, Yang CH, Rao ZY, Zhang XZ
Nature nanotechnology 2025 Jul;20(7):935-946
Nature nanotechnology 2025 Jul;20(7):935-946
Dominant follicle-targeted nanocarriers for GH delivery to alleviate premature ovarian insufficiency.
Yang S, Sun Y, Luo W, Zhou X, Gu X, Zhang W, Zhu H, Wu W, Wu X, Yu M, Wang S
Materials today. Bio 2025 Aug;33:101930
Materials today. Bio 2025 Aug;33:101930
WEE1 inhibitor exerts synergistic effect with KRAS G12C inhibitor via MYBL2-RRM2 axis in KRAS(G12C)-mutant lung cancer.
Zhou C, Liu Y, Liu H, Lu J, Zhang B, Zhu L, Wang S, Lei H, Han B
Cell death & disease 2025 Aug 30;16(1):661
Cell death & disease 2025 Aug 30;16(1):661
Clinical characteristics of gastrointestinal stromal tumors with hypoglycemia.
Chida A, Kawasaki K, Kuramoto J, Hayashi H, Kawahara T, Makiuchi S, So E, Shimizu S, Kishimoto S, Horie S, Saito Y, Shimozaki K, Tsugaru K, Togasaki K, Hirata K, Nishihara H, Kanai Y, Kanai T, Hamamoto Y
Oncology letters 2024 Dec;28(6):568
Oncology letters 2024 Dec;28(6):568
Celastrol inhibits gastric cancer cell proliferation, migration, and invasion via the FOXA1/CLDN4 axis.
Peng W, Chen L, Liu J
Toxicology research 2023 Jun;12(3):392-399
Toxicology research 2023 Jun;12(3):392-399
Tectonic 1 Is a Key Regulator of Cell Proliferation in Pancreatic Cancer.
Zhao S, Chen X, Wan M, Jiang X, Li C, Cui Y, Kang P
Cancer biotherapy & radiopharmaceuticals 2016 Feb;31(1):7-13
Cancer biotherapy & radiopharmaceuticals 2016 Feb;31(1):7-13
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- The UNKL antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human UNKL. This antibody recognizes human,mouse,rat antigen. The UNKL antibody has been validated for the following applications: ELISA, WB analysis.